Medicare Enrolled

Dr. Ali Rezaie

Optician · West Hollywood, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
8700 BEVERLY BLVD, West Hollywood, CA 90048
3104236143
In practice since 2014 (12 years)
NPI: 1356765739 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rezaie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rezaie? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rezaie

Dr. Ali Rezaie is an optician specialist in West Hollywood, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Rezaie performed 532 Medicare services across 388 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rezaie received a total of $597,797 from 8 pharmaceutical and/or device companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rezaie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 532 Medicare services $597,797 industry payments

Medicare Practice Summary

Medicare Utilization ↗
532
Medicare services
Bottom 32% in CA for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
388
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hydrogen breath test
A test that measures hydrogen levels in your breath to help evaluate stomach and bowel symptoms.
172 $8 $33
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
128 $76 $322
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
30 $51 $218
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
30 $111 $468
Rectal sensitivity and function study
A test to evaluate the sensitivity and functional performance of the rectum.
26 $68 $283
Esophageal motility study
A test that evaluates the movement and function of the esophagus.
25 $52 $210
Esophageal function monitoring via nasal tube
This procedure involves monitoring and recording esophageal function using a tube inserted through the nose that contains electrodes.
25 $40 $159
Rectal and anal tone and sensation test
A physical examination to assess muscle tone and sensory function in the rectum and anus.
25 $40 $156
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $65 $244
Biofeedback training for bowel or bladder control, initial 15 minutes
A 15-minute session using biofeedback techniques to help patients gain control over bowel or bladder functions. The training involves monitoring physiological processes to learn how to manage muscle activity.
20 $33 $156
Biofeedback training for bowel or bladder control, each additional 15 minutes
This procedure involves additional 15-minute sessions of biofeedback training to help improve control over bowel or bladder functions.
19 $20 $81
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
11 $97 $576
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$597,797
Total received (2018-2024)
Avg $85,400/year across 7 years
Top 1% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
8
Companies
641
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$585,204 (97.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,287 (2.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$305 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$63,349
2023
$69,003
2022
$100,528
2021
$76,756
2020
$10,651
2019
$98,216
2018
$179,293

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56,706
Ardelyx, Inc.
$3,680
Blueprint Medicines Corporation
$2,696
Vibrant Gastro, Inc.
$142
Phathom Pharmaceuticals, Inc.
$125
Top 3 companies account for 99.6% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$498,682
Synergy Pharmaceuticals Inc
$82,642
Alnylam Pharmaceuticals Inc.
$7,551
Ardelyx, Inc.
$5,720
Blueprint Medicines Corporation
$2,696
Vibrant Gastro, Inc.
$342
Phathom Pharmaceuticals, Inc.
$125
Regeneron Pharmaceuticals, Inc.
$38
Top 3 companies account for 98.5% of all-time payments
Associated products mentioned in payments ›
DUPIXENT · GIVLARRI · IBSRELA · OXLUMO · RELISTOR · RIFAXIMIN · TRULANCE · Trulance · VOQUEZNA · Vibrant Starter Kit · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in CA.

Looking for an optician specialist in West Hollywood?
Compare opticians in the West Hollywood area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,540
Per 100K population
15.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rezaie is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rezaie experienced with hydrogen breath test?
Based on Medicare claims data, Dr. Rezaie performed 172 hydrogen breath test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rezaie receive payments from pharmaceutical companies?
Yes. Dr. Rezaie received a total of $597,797 from 8 companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rezaie's costs compare to other opticians in West Hollywood?
Dr. Rezaie's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rezaie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →